Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 227

1.

Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.

Yothers G, Sargent DJ, Wolmark N, Goldberg RM, O'Connell MJ, Benedetti JK, Saltz LB, Dignam JJ, Blackstock AW; ACCENT Collaborative Group.

J Natl Cancer Inst. 2011 Oct 19;103(20):1498-506. doi: 10.1093/jnci/djr310. Epub 2011 Oct 12.

PMID:
21997132
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Adjuvant colon cancer chemotherapy: where we are and where we'll go.

Lombardi L, Morelli F, Cinieri S, Santini D, Silvestris N, Fazio N, Orlando L, Tonini G, Colucci G, Maiello E.

Cancer Treat Rev. 2010 Nov;36 Suppl 3:S34-41. doi: 10.1016/S0305-7372(10)70018-9. Review.

PMID:
21129608
[PubMed - indexed for MEDLINE]
3.

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, French AJ, Kabat B, Foster NR, Torri V, Ribic C, Grothey A, Moore M, Zaniboni A, Seitz JF, Sinicrope F, Gallinger S.

J Clin Oncol. 2010 Jul 10;28(20):3219-26. doi: 10.1200/JCO.2009.27.1825. Epub 2010 May 24. Erratum in: J Clin Oncol. 2010 Oct 20;28(30):4664.

PMID:
20498393
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.

Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM; Norwegian Gastrointestinal Cancer Group.

Acta Oncol. 2009;48(3):368-76. doi: 10.1080/02841860902755244.

PMID:
19242829
[PubMed - indexed for MEDLINE]
5.

Adjuvant treatment of colon cancer: past, present and future.

Wils J.

J Chemother. 2007 Apr;19(2):115-22. Review.

PMID:
17434818
[PubMed - indexed for MEDLINE]
6.

Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.

Nehls O, Okech T, Hsieh CJ, Enzinger T, Sarbia M, Borchard F, Gruenagel HH, Gaco V, Hass HG, Arkenau HT, Hartmann JT, Porschen R, Gregor M, Klump B.

Br J Cancer. 2007 May 7;96(9):1409-18. Epub 2007 Apr 10.

PMID:
17426704
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.

van Geelen CM, Westra JL, de Vries EG, Boersma-van Ek W, Zwart N, Hollema H, Boezen HM, Mulder NH, Plukker JT, de Jong S, Kleibeuker JH, Koornstra JJ.

J Clin Oncol. 2006 Nov 1;24(31):4998-5004.

PMID:
17075118
[PubMed - indexed for MEDLINE]
8.

Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.

O'Connell MJ, Sargent DJ, Windschitl HE, Shepherd L, Mahoney MR, Krook JE, Rayson S, Morton RF, Rowland KM Jr, Kugler JW.

Clin Colorectal Cancer. 2006 Jul;6(2):133-9.

PMID:
16945169
[PubMed - indexed for MEDLINE]
9.

Levamisole-induced multifocal inflammatory leukoencephalopathy: clinical characteristics, outcome, and impact of treatment in 31 patients.

Wu VC, Huang JW, Lien HC, Hsieh ST, Liu HM, Yang CC, Lin YH, Hwang JJ, Wu KD.

Medicine (Baltimore). 2006 Jul;85(4):203-13.

PMID:
16862045
[PubMed - indexed for MEDLINE]
10.

[Progression of adjuvant chemotherapy for colon cancer].

He YJ, Dong QM, Li YH.

Ai Zheng. 2005 Dec;24(12):1546-9. Review. Chinese.

PMID:
16351811
[PubMed - indexed for MEDLINE]
11.

Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice?

Van Cutsem E, Costa F.

JAMA. 2005 Dec 7;294(21):2758-60. No abstract available.

PMID:
16333012
[PubMed - indexed for MEDLINE]
12.

Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.

Jessup JM, Stewart A, Greene FL, Minsky BD.

JAMA. 2005 Dec 7;294(21):2703-11.

PMID:
16333005
[PubMed - indexed for MEDLINE]
13.

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

Haller DG, Catalano PJ, Macdonald JS, O'Rourke MA, Frontiera MS, Jackson DV, Mayer RJ.

J Clin Oncol. 2005 Dec 1;23(34):8671-8.

PMID:
16314627
[PubMed - indexed for MEDLINE]
14.

Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha.

Link KH, Kornmann M, Staib L, Redenbacher M, Kron M, Beger HG; Study Group Oncology of Gastrointestinal Tumors.

Ann Surg. 2005 Aug;242(2):178-87.

PMID:
16041207
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.

Schippinger W, Jagoditsch M, Sorré C, Gnant M, Steger G, Hausmaninger H, Mlineritsch B, Schaberl-Moser R, Mischinger HJ, Hofbauer F, Holzberger P, Mittlböck M, Jakesz R; Austrian Breast and Colorectal Cancer Study Group.

Br J Cancer. 2005 May 9;92(9):1655-62.

PMID:
15856042
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.

Poplin EA, Benedetti JK, Estes NC, Haller DG, Mayer RJ, Goldberg RM, Weiss GR, Rivkin SE, Macdonald JS.

J Clin Oncol. 2005 Mar 20;23(9):1819-25.

PMID:
15774775
[PubMed - indexed for MEDLINE]
17.

Experimental assessment of chemotherapy-induced early intestinal damage in colon cancer the lactulose-mannitol permeability test.

Sukkar SG, Schenone E, Foppiani L, Nobile MT.

Tumori. 2004 Sep-Oct;90(5):461-3.

PMID:
15656329
[PubMed - indexed for MEDLINE]
18.

Encephalopathy induced by antihelminthic use of levamisole: report of two patients.

El Kallab K, El Khoury J, Elias E, Chelala A.

J Med Liban. 2003 Oct-Dec;51(4):221-7.

PMID:
15623138
[PubMed - indexed for MEDLINE]
19.

Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.

Sobrero A, Frassineti G, Falcone A, Dogliotti L, Rosso R, Di Costanzo F, Bruzzi P; INTACC.

Br J Cancer. 2005 Jan 17;92(1):24-9. Erratum in: Br J Cancer. 2005 Sep 19;93(6):733. Costanzo, FD [corrected to Di Costanzo, F].

PMID:
15611795
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.

Martenson JA Jr, Willett CG, Sargent DJ, Mailliard JA, Donohue JH, Gunderson LL, Thomas CR Jr, Fisher B, Benson AB 3rd, Myerson R, Goldberg RM.

J Clin Oncol. 2004 Aug 15;22(16):3277-83. Epub 2004 Jul 12.

PMID:
15249584
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk